SCIASCIA THOMAS

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SCIASCIA THOMAS's trades of Trevi Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
169.46
Quantity 22,435 -20.7%
Value US$2,749,423
Transaction date
Proposed sale
Price
2.61
Quantity 48,001
Value US$125,282
Transaction date
Sale
Price
2.75
Quantity 100 -0.0%
Value US$275
Transaction date
Proposed sale
Price
2.56
Quantity 53,368
Value US$136,622
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-26 2025-03-25
S Sale
22,435 -20.7%
169.46
US$2,749,423 		22,435 -20.7% 169.46 US$2,749,423
2024-08-21 2024-08-19
S Sale
71,071 +13.5%
118.84
US$4,231,031 		71,071 +13.5% 118.84 US$4,231,031
2024-08-16 2024-08-16
S Sale
51,591 +15.4%
148.77
US$4,791,455 		51,591 +15.4% 148.77 US$4,791,455
2024-08-16 2024-08-15
S Sale
12,745 -5.5%
2.79
US$35,513 		12,745 -5.5% 2.79 US$35,513
2024-08-15 2024-08-15
PrS Proposed sale
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-15 2024-08-15
PrS Proposed sale
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-16 2024-08-14
S Sale
100 -0.0%
2.75
US$275 		100 -0.0% 2.75 US$275
2024-05-31 2024-05-29
PlS Planned sale
53,368 -19.9%
2.55
US$136,110 		53,368 -19.9% 2.55 US$136,110
2024-05-29 2024-05-29
PrS Proposed sale
53,368
2.56
US$136,622 		53,368 2.56 US$136,622